phase readout
saveNCT06564324: A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
RECRUITINGupdated 1h ago
community read0 votes
Sponsor: Nuvation Bio Inc.. Phase: PHASE3. Conditions: Non Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that